Navigation Links
Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
Date:5/15/2013

learned during the past decade of the Company's Generx clinical development program.
  • Publication of the paper, "Mechanistic, Technical, and Clinical Perspectives in Therapeutic Stimulation of Coronary Collateral Development by Angiogenic Growth Factors," authored by Gabor M. Rubanyi, M.D., Ph.D., Cardium's Chief Scientific Officer, in the April issue of Molecular Therapy publication.  The publication outlines current scientific knowledge about the mechanistic basis of adaptive coronary collateral growth, the biological processes to be targeted by therapeutic angiogenesis, and the optimization of clinical trial designs, including the Generx ASPIRE Phase 3 / registration study.
  • Expanded To Go Brands® VitaRocks® kids vitamin product line and broadened retail distribution of the newly-designed products into select nationwide Target stores.  Because of the unique manufacturing process of To Go Brands' VitaRocks platform, the Company now has the flexibility to expand the product line into formulas that could include enzymes, electrolytes, amino acids, vitamins and minerals, as well as nutrients, and into other applications including Over-the-Counter (OTC) drugs.
  • (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

    Financial ReportProduct sales for the three months ended March 31, 2013 totaled $599,000, compared to $20,000 for the same period in 2012. The increase in sales during the first quarter 2013 reflects sales from Cardium's To Go Brands health science-based operating unit (representing approximately 92% of total product sales) and sales of Cardium's Excellagen advanced wound care product (8% of total product sales). 

    Cardium's research and development costs for the first three months ended March 31, 2013 totaled $762,000, compared to $1.2 million for the three months ended March 31, 2012.
    '/>"/>

    SOURCE Cardium Therapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Cardium Announces Generx Publication In Molecular Therapy
    2. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
    3. Cardium Presents Year-End 2012 Financial Results And Recent Developments
    4. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
    5. Cardium Receives ISO Certification for Excellagen
    6. Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
    7. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
    8. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
    9. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
    10. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
    11. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/1/2015)... Calif. , June 1, 2015   ... a biopharmaceutical company leading the discovery and development ... Kleanthis G. Xanthopoulos , Ph.D. has resigned ... a member of Regulus, Board of Directors, effective ... industry.  Paul Grint, M.D., who previously served as ...
    (Date:6/1/2015)... 1, 2015 About Pressure ... large area and improve the quality life of patients ... devices play a significant role in inhibiting the growth ... need to turn or rotate an immobile patient by ... mattresses overlay, and specialty beds. These devices have the ...
    (Date:6/1/2015)... , June 1, 2015 NEOVIA ... company engaged in the development and commercialization of ... that it has met with the U.S. Food ... the filing of an Investigational New Drug (IND) ... As a result of the meeting, Neovia has ...
    Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Neovia Oncology Announces First IND Meeting 2
    ... Therapeutics (NYSE Amex: CXM ) today ... a topically applied formulated collagen wound management gel ... factor (PDGF) locally at the wound site.  This ... essential role in the wound healing process. ...
    ... Prime Therapeutics (Prime), a thought leader in ... awarded full Pharmacy Benefit Management (PBM) accreditation from ... that establishes quality standards for the health care ... URAC accreditation in 2007, and has also achieved ...
    Cached Medicine Technology:Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 2Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 3Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 4Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 5Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 6Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 7Prime Therapeutics Announces URAC Accreditation 2
    (Date:6/2/2015)... 02, 2015 Glidewell Laboratories, industry-leading ... today that the new issue of Chairside® magazine, ... and online. The digital edition of the latest ... past issues of the dental laboratory’s magazine, can ... smartphone platforms by visiting http://www.chairsidemagazine.com . , ...
    (Date:6/2/2015)... 02, 2015 The Non-GMO Project ... products made according to rigorous best practices for ... produced in compliance with the Non-GMO Project Standard ... risk ingredients, facility inspections and an annual audit ... avoidance. , “Savoury Systems is and has always ...
    (Date:6/2/2015)... 02, 2015 Mercy Health (formerly Catholic ... and Kentucky – has devoted the seventh of its ... skin cancer prevention. One in five Americans will get ... Health’s YouTube channel, a Mercy Health expert addresses these ... main causes of skin cancer? ,     What are ...
    (Date:6/2/2015)... June 02, 2015 The Radiosurgery ... study from the RSSearch® Patient Registry evaluating the ... radiotherapy (SBRT) for the treatment of centrally located ... metastases. , The study, published in the ... ), included 111 patients with 114 centrally located ...
    (Date:6/2/2015)... Dallas, TX (PRWEB) June 02, 2015 FDA ... to qualified Diet Doc patients after a satisfactory doctor consultation. ... on the market for several years and has the longest ... Working to block the enzyme that breaks down fats in ... diverting them through the intestinal system to be excreted through ...
    Breaking Medicine News(10 mins):Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 2Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 3Health News:Savoury Systems International Receives Non-GMO Project Verification Continuing its Commitment to Provide Customers with Clean Label Ingredients 2Health News:Video provides helpful information about skin cancer prevention 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 3Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 2Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 3Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 4
    ... technology that was developed for an aerospace high-speed ... device for heart failure patients.(Logo: http://www.newscom.com/cgi-bin/prnh/20081007/38461LOGO )NASA,s ... advanced aerospace resin, named Langley Research Center,s Soluble ... to chemicals, and withstands extreme hot and cold ...
    ... Senate recently introduced legislation that would increase access to ... need for a physician,s referral or certification of the ... access is authorized, says the American Physical Therapy Association ... Therapists Act (S 950), introduced by Senators Blanche Lincoln ...
    ... Increased Case Volume Continue to Drive Revenue GrowthALISO VIEJO, Calif., ... (Nasdaq: CLRT ), a premier ... and the pharmaceutical industry, today reported $22.4 million in revenue ... increase as compared with $15.9 million for the same period ...
    ... a.m. Central Daylight Time. HOUSTON, May 6 Service Corporation International (NYSE: SCI ), ... Our consolidated financial statements can be found at the end of this press release. ... ... ...
    ... May 6 The Generic Animal Drug Alliance ... animal health industry interests, says that the recent ... illustrates the potential safety issues surrounding compounded drugs ... Food and Drug Administration (FDA) approved animal generic ...
    ... of the nation,s leading cardioelectrophysiologists, has joined The Mount Sinai Medical ... ... York, NY (Vocus)-- Vivek Y. Reddy, M.D., one of the nation,s ... as Director of Electrophysiology Laboratories. His appointment becomes effective July ...
    Cached Medicine News:Health News:Cardiac Patients Take NASA Super Plastic to Heart 2Health News:Cardiac Patients Take NASA Super Plastic to Heart 3Health News:Senate Introduces Legislation to Increase Access to Physical Therapist Services 2Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 2Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 3Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 4Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 5Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 6Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 7Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 8Health News:Clarient Reports 41% Revenue Increase for First Quarter 2009 9Health News:Service Corporation International Announces First Quarter 2009 Financial Results 2Health News:Service Corporation International Announces First Quarter 2009 Financial Results 3Health News:Service Corporation International Announces First Quarter 2009 Financial Results 4Health News:Service Corporation International Announces First Quarter 2009 Financial Results 5Health News:Service Corporation International Announces First Quarter 2009 Financial Results 6Health News:Service Corporation International Announces First Quarter 2009 Financial Results 7Health News:Service Corporation International Announces First Quarter 2009 Financial Results 8Health News:Service Corporation International Announces First Quarter 2009 Financial Results 9Health News:Service Corporation International Announces First Quarter 2009 Financial Results 10Health News:Service Corporation International Announces First Quarter 2009 Financial Results 11Health News:Service Corporation International Announces First Quarter 2009 Financial Results 12Health News:Service Corporation International Announces First Quarter 2009 Financial Results 13Health News:Service Corporation International Announces First Quarter 2009 Financial Results 14Health News:Service Corporation International Announces First Quarter 2009 Financial Results 15Health News:Service Corporation International Announces First Quarter 2009 Financial Results 16Health News:Service Corporation International Announces First Quarter 2009 Financial Results 17Health News:Service Corporation International Announces First Quarter 2009 Financial Results 18Health News:Service Corporation International Announces First Quarter 2009 Financial Results 19Health News:Service Corporation International Announces First Quarter 2009 Financial Results 20Health News:Service Corporation International Announces First Quarter 2009 Financial Results 21Health News:Service Corporation International Announces First Quarter 2009 Financial Results 22Health News:GADA Points to Safety of FDA Approved Generics in Wake of Wellington Polo Horse Deaths from Compounded Drugs 2Health News:Vivek Y. Reddy, M.D., Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories 2Health News:Vivek Y. Reddy, M.D., Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories 3
    ...
    ...
    ...
    Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
    Medicine Products: